Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03592264 |
| Title | This Study is to Evaluate OBI-3424 Safe and Effective Treatment Dose in Subjects With Hepatocellular Carcinoma or Castrate Resistant Prostate Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | OBI Pharma, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Scripps Clinic Torrey Pines | NOT_YET_RECRUITING | La Jolla | California | 92037 | United States | Details |
| USC Norris Comprehensive Cancer Center | NOT_YET_RECRUITING | Los Angeles | California | 90033 | United States | Details |
| Rutgers Cancer Institute of New Jersey | NOT_YET_RECRUITING | New Brunswick | New Jersey | 08903 | United States | Details |
| Ohio State University Comprehensive Cancer Center | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
| MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |